title: Two Draft FDA Guidance Documents Stir Controversy: Hospital and 503B Pharmacy Repackaging and Compounding Are at Issue.
abstract: The Food and Drug Administration hopes to close gaps in laws related to repackaging of pharmaceuticals or biologics by hospital pharmacies and bulk compounding facilities.
authors.forename: Stephen
authors.initials: S
authors.lastname: Barlas